Adults aged 20 years or older diagnosed with T2DM between 2016 and 2024 were included if they received any hypoglycemic agents within 3 months before and after diagnosis
In a 12-week, randomized, doubleblind, placebocontrolled crossover trial of weekly 1.0 mg semaglutide in adults with obesity, participants reduced total daily energy intake by about 24% and lost an average of 5 kg compared to placebo
Combining GLP1s with Hormone Therapy for Greater Weight Loss Research indicates that combining GLP1 weight loss shots with hormone therapy may boost weight loss results by up to 30 percent compared to using GLP1 medications alone
Intramuscular and IV routes require sterile compounding and clinical supervision
Hong Y, Lee JH, Jeong KW, Choi CS, Jun HS
Sexual dimorphism in immunity and longevity among the oldest old